Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune…
Has more than 30 years of experience bringing innovations to market, including one of the world’s first drug-eluting coronary stents…
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025UK Clinical Trial Application (CTA) approval shortly…
August 04, 2025 08:05 ET | Source: MaxCyte, Inc MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of…
TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) today announced the formation of QUBEE…
August 04, 2025 08:05 ET | Source: RxSight, Inc. ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) –…
August 04, 2025 06:00 ET | Source: Nano Labs Ltd. HONG KONG, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Nano Labs…
Stockholm, 4th of August 2025 – Virtune AB (Publ) ("Virtune") today announces that it has completed the monthly rebalancing of…
VICTORIA, Seychelles, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WEEX, a leading cryptocurrency exchange successfully completed its second-quarter burn of WEEX…
August 01, 2025 16:15 ET | Source: ImageneBio, Inc. SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq:…